Vedolizumab Earning Its Place as a Treatment for Chronic Pouchitis

Gastroenterology. 2023 Dec;165(6):1574-1575. doi: 10.1053/j.gastro.2023.05.026. Epub 2023 May 27.

Author

Jonathan P Segal¹

Affiliation

¹ Department of Gastroenterology, Royal Melbourne Hospital and, Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.

PMID: 37247641
DOI: 10.1053/j.gastro.2023.05.026

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Chronic Disease
Colitis, Ulcerative* / diagnosis
Colitis, Ulcerative* / drug therapy
Colitis, Ulcerative* / surgery
Humans
Pouchitis* / diagnosis
Pouchitis* / drug therapy
Proctocolectomy, Restorative* / adverse effects

Substances

vedolizumab
Antibodies, Monoclonal, Humanized